NewsRoom Articles - Page 169 of 241

WednesdaySep 15, 2021 1:43 pm

Potential for Psychedelic treatments Drives Mind Cure Health Inc.’s (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Strategy for Therapeutics Profitability

Canada-based life sciences company Mind Cure Health is developing a synthetic form of the psychedelic drug ibogaine as part of its efforts to take a leading position in the burgeoning market for mental health therapies Psychedelics, strengthened by new clinical research driving scientific and legislative openness to the drugs’ possible benefits under controlled conditions, are overcoming stigmas that arose from recreational use of the drug Mind Cure Health is developing a proprietary software-as-a-service (SaaS) platform known as iSTRYM to optimize the healing journey between patients and caregivers The company recently released its year-end financial report and an analysis outlining…

WednesdaySep 15, 2021 12:30 pm

Study Finds Fibromyalgia May Be Caused By Antibodies

A new study conducted by researchers at King’s College London, in collaboration with the Karolinksa Institute and the University of Liverpool, has found that fibromyalgia syndrome is an illness caused by the immune system. The researchers discovered that most symptoms of this syndrome were caused by antibodies that increased pain-sensing nerve activity in the body. Estimates show that one in every 40 individuals is affected by fibromyalgia syndrome globally, with figures showing that of this number, roughly 80% are female. The disease is commonly characterized by emotional distress, fatigue and widespread pain throughout an individual’s body. While children can also…

TuesdaySep 14, 2021 12:19 pm

New Prototype Device Eliminates Radiation Exposure from Breast Cancer Screening

Breast cancer is the second-leading cause of cancer death in women. Now scientists at the University of Waterloo have designed a system that could help save the lives of many women by routinely screening them for breast cancer without exposing them to radiation. This new and inexpensive technology uses artificial intelligence (“AI”) software and harmless microwaves to detect small early-stage tumors in minutes. Some studies have found that small tumors can be aggressive, which makes it even more important for women to begin screening for breast cancer regularly. A professor of electrical and computer engineering at the institution, Omar Ramahi…

TuesdaySep 14, 2021 9:48 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Likely to Benefit from New Research Touting Psilocybin Mental Health Treatments

Yale researchers publish study that a single dose of psilocybin counteracts symptoms of depression Administering drug to mice resulted in an approximately 10% increase in neuron size and density Cybin is focused on progressing psychedelic therapeutics As news of psychedelic research continues to report breakthroughs — such as the recent news from a group of Yale researchers that a single dose of psilocybin counteracts symptoms of depression (https://ibn.fm/NCORl) — companies operating in the space, including Cybin (NEO: CYBN) (NYSE American: CYBN), are ideally positioned to see significant benefits and growth. “Yale researchers found that a single dose of the naturally occurring psychedelic compound psilocybin…

MondaySep 13, 2021 2:10 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), Innovation, Partnerships, and Leadership: A 2021 Outlook

So far in 2021, Tryp’s innovations have allowed it to position itself as a first-mover in the psychedelics space The company has announced completion of psychotherapy training for the upcoming phase 2a clinical trials for specific overeating disorders Tryp has also been keen on collaborating and partnering with key players in the industry, such as Calvert Labs and Gad Consulting services, the University of Michigan, and the University of Florida The company also understands the value of proper leadership and, so far in 2021, it has made strategic appointments to its board of directors Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF)…

MondaySep 13, 2021 1:05 pm

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Files for National Medical Products Administration Registration of Early-Warning Cancer Technology with a Record 11 Tumor Types Under Formal Medical Device Product Registration

AnPac Bio-Medical Science Co., Ltd. has developed its proprietary Cancer Differentiation Analysis (“CDA”) technology to detect biophysical signals as an alternative early disease indicator to blood-based biomarker testing for cancer The company has laboratories and R&D facilities in China equipped for CDA testing and cancer biochemical testing, as well as a CLIA/CAP accredited laboratory in the United States AnPac Bio recently held its 2021 technical symposium in China where KOLs from major hospitals and universities discussed new technologies for cancer detection and treatment. AnPac Bio-Medical Science (NASDAQ: ANPC) is moving forward with testing and registration of its multi-cancer screening technology…

MondaySep 13, 2021 12:08 pm

An Overview of Ibogaine as an Addiction Treatment

Ibogaine is a compound that is found in a mid-sized shrub known as Tabernanthe iboga, which is native to central-west Africa. Early research and anecdotal evidence suggests that the compound may be used to decrease symptoms of alcohol and drug withdrawal, reduce the risk of recurrent use and ease cravings. The Bwiti religion, practiced in West Central Africa (especially in Gabon, Cameroon as well as the Republic of Congo), uses various parts of the shrub for certain religious (such as during coming of age rituals and welcoming initiates into the religion) and healing purposes, as it possesses anesthetic properties. For example,…

FridaySep 10, 2021 12:20 pm

Four Lifestyle Changes That May Benefit Individuals with Sleep Apnea

Sleep apnea is a common and serious sleep disorder that affects an individual’s breathing during sleep. Undiagnosed and untreated sleep apnea can worsen an individual’s mood, raise their blood pressure and even stress the heart. Some people suffering from this disorder use a device known as a continuous positive airway pressure device, which enables easier breathing. However, making some lifestyle changes may also help sleep apnea patients sleep better. Below are a few changes that may be beneficial to patients with sleep apnea. Avoid some medications Opioids are known to relax the body’s breathing muscles and slow down an individual’s…

FridaySep 10, 2021 9:00 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) CEO Discusses Psychedelics, Company’s Progress, Plans, Business in a Recent Bell2Bell Podcast Interview

Mind Cure Health Inc. CEO Kelsey Ramsden was featured in a recent Bell2Bell podcast interview, during which she explained the company’s primary focal points – digital therapeutics and drug development On the digital therapeutics side of its business, the company is developing iSTRYM, a clinical-grade, evidence-backed, science-based, AI-driven tool for both therapists and patients, scheduled for full commercial launch in Q1 2022 MCUR has successfully synthesized the chemically complex ibogaine and intends to scale up its production during the remainder of 2021 As a diversified life sciences company at the forefront of the mental health industry, Mind Cure Health (CSE:…

FridaySep 10, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Publishes Report Outlining Cannabis Treatments for Conditions Associated with HIV and AIDS

RYAH releases report outlining ways cannabis is being used to treat conditions associated with HIV and AIDS Report data compiled by RYAH Data Ecosystem between January 1, 2018, and August 26, 2021 Data includes specific HIV and AIDS conditions, details cannabis strains used by patients Three-part RYAH Data Ecosystem includes volume control and management devices, QR tracking to identify product formulations and parameters, mobile apps to manage information and provide feedback With a mission to advance remote-health solutions and analytics-based patient treatments across the world, RYAH Group (CSE: RYAH) (formerly RYAH Medtech) is the leader in volume control and management…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Potential for Psychedelic treatments Drives Mind Cure Health Inc.’s (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Strategy for Therapeutics Profitability

Study Finds Fibromyalgia May Be Caused By Antibodies

New Prototype Device Eliminates Radiation Exposure from Breast Cancer Screening

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Likely to Benefit from New Research Touting Psilocybin Mental Health Treatments

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), Innovation, Partnerships, and Leadership: A 2021 Outlook

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Files for National Medical Products Administration Registration of Early-Warning Cancer Technology with a Record 11 Tumor Types Under Formal Medical Device Product Registration

An Overview of Ibogaine as an Addiction Treatment

Four Lifestyle Changes That May Benefit Individuals with Sleep Apnea

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) CEO Discusses Psychedelics, Company’s Progress, Plans, Business in a Recent Bell2Bell Podcast Interview

RYAH Group Inc. (CSE: RYAH) Publishes Report Outlining Cannabis Treatments for Conditions Associated with HIV and AIDS

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search